Introduction {#S1}
============

Beta Thalassemia major, also called Cooley disease, is a severe transfusion-dependent anaemia which often causes infertility due to the iron deposits in endocrine organs following multiple blood transfusions, needed to care this illness. Gonadal function is impaired in the majority of the patients affected by the homozygous kind of this disease and, especially in females, this is expressed either by a delay in the onset of puberty and menstruation or by secondary amenorrhoea.^[@R1]^ The commonest abnormality was hypogonadotropic hypogonadism, but the relatively high prevalence of other endocrine impairments, causing multiple endocrinopathies, is also well recognised. These kind of endocrine complications are directly related to the serum ferritin level.^[@R2]^ The aetiology of the above mentioned reproductive disorders is linked to an anatomical and functional disarray of the components of the central nervous system-gonadal axis and the functionality is often impaired at all three levels, i.e. gonads, anterior pituitary and hypothalamus.^[@R3]--[@R5]^ Up to the end of 1980 there were only some reports of pregnancy in patients with beta Thalassemia major and, only few of them were carried out successfully.^[@R6]--[@R8]^ Nowadays, thanks to improved paediatric and haematological cares, patients affected by Cooley disease may live on to be forty or fifty, and can enjoy a quite regular standard of life. So that, maintaining a strict therapeutic regimen, women regularly transfused and well chelated can attempt to become pregnant.^[@R9]--[@R12]^ In this report we describe the evolution and the successful outcome of five at term pregnancies carried out by four women affected by transfusion dependent beta Thalassemia. In reviewing the cares and the complications during and after their pregnancies, we discuss the issue concerning the appropriate preconception counselling of such patients.

Materials and Methods {#S2}
=====================

For several years we have been following one hundred women affected by transfusion dependent beta Thalassemia major, diagnosed when they were between 6 and 8 months old, from the endocrine and reproductive point of view. All of them, who attended the Paediatric Institute of Catania University, were aged between 23 to 29 and received a blood transfusion every 15--20 days, in order to maintain the haemoglobin concentration above 10 g/dL; and were in strict desferrioxamine chelating therapy, to avoid excessive iron overloads. The patients have been divided into three groups according to their first and successive menstruation characteristics: i) patients with primitive amenorrhoea, ii) patients with secondary amenorrhoea and iii) patients with normal menstruation. In detail twenty out of these women got married: four were affected by primitive amenorrhoea; six were affected by secondary one and the remaining ten women had normal menstruation. Finally five pregnancies occurred among these twenty women: two among the patients affected respectively by primitive and secondary amenorrhoea, and three were carried out by women with spontaneous menstruation. Considering as to the last three pregnancies, it is remarkable that to this group belonged a woman that had two successful childbirths; so the total number of women we followed was four ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}; [Table 1](#T1){ref-type="table"}). Average values of ferritin fluctuated between 500 and 1000 ng/mL, and transaminases were between 25 and 100 U/L. All of them were vaccinated against Hepatitis B Virus (HBV), and two were splenectomized, particularly the woman affected by primitive amenorrhoea and one of those with normal periods. Only the woman affected by primitive amenorrhoea needed the induction of ovulation to stimulate her pregnancy. Evaluation of eligibility depends upon the results of a series of examinations regarding hearth, kidneys, thyroid, pancreas and peripheral arteries. Haemosiderotic parenchimal deterioration, particularly of the myocardium, makes these patients potentially fragile, while the induction of ovulation may be a hard stress test even for a healthy woman. All the other women had spontaneous and physiological pregnancies. It is finally important to underline that all the partners of these women were negative as regards the thalassemic trait. According to the guidelines previously established by Susan M. Tuck,^[@R13]^ a precise and detailed pre-pregnancy assessment was effected before each conception. This was constituted by a series of clinical and laboratory essays, including checks for diabetes and hypothyroidism, for B and C hepatitis and for blood group antibodies. Cardiac function was assessed symptomatically and by echocardiography and exercise electrocardiography. Rubella immunity was checked and immunisation was given when the woman was found to be susceptible. During pregnancy the monitoring of all these factors continued, including frequent checks of aminotransferase (AST and ALT transaminases). The frequency of blood transfusion had to be increased, the aim being to maintain the pre-transfusion haemoglobin concentration. Desferrioxamine therapy was stopped as soon as pregnancy was diagnosed, because using this drug during gestation could notoriously induce teratogenic effects on the foetus, but the average values of ferritin were just a little higher than the normal range observed. Probably the foetus, due to a particular chelating activity, maintains it during gestation. This therapy was quickly resumed after delivery.^[@R14]^ Other pregnancy monitoring, such as for blood pressure, for proteinuria and for fetal growth, and cares during labour and delivery were effected according to usual obstetrics practice and criteria.

Figure 1Flow chart representing the distribution of 100 women affected by Beta Thalassemia major subdivided in three categories, according to their menstruation characteristics; considering if they are married or singles, and the number of pregnancies carried out by each group.

Figure 2Graphic expressing the percentage of married women in reference to each group in which we subdivided them.

Table 1Table expressing the number of married women, the pregnancies, the medium age and the amount of each group, according to a subdivision in three categories -Normal menstruation, Secondary Amenorrhoea and Primitive Amenorrhoea -- in reference to the total amount of the 100 patients we studied.Menstruation characteristicsNormal MenstruationSecondary amenorrheaPrimary amenorrheaMarried women1064Number of pregnancy3 (30%)1 (16.6%)1 (25%)Spontaneous pregnancy3 (100%)1 (100%)-Induced pregnancy\--1 (100%)Medium Age21.4±2.223.7±1.925.1±3.4

Results {#S3}
=======

Only one out of the five pregnancies we have followed needed the induction of ovulation. Moreover a same woman carried out two of them. All the women were in labour when she were 38 week pregnant, and the outcome were five healthy babies born at term weighting between 2600 and 3200gs. The caesarean delivery was preferred because of the frequent *infertility/sterility* that occurs in the natural history of such kind of patients. All of these women were neither HIV positive nor suffered from diabetes, however they were controlled with a diet. All of them reported transaminases raising, but only in one case it was necessary to practice a therapy based on silimarina. Moreover all of them had transfusion-transmitted C hepatitis prior to pregnancy, but only the one affected by secondary amenorrhoea received curses of interferon two years before embarking on pregnancy, because she showed to be positive for HCV-RNA. Four out of the babies born were HCV negative, while only one was HCV positive but HCV-RNA negative, so that it was not necessary to prescribe a therapy.

Finally, there were neither cardiac dysfunctions nor kidney diseases reported, or other important affections.

Discussion {#S4}
==========

We believe that several ethical and theoretical questions should be evaluated before the observation of technical problems. We should never forget that Beta thalassemic are fragile patients who are knowingly exposed to a large quantity of risks. It is the doctor\'s responsibility to decide which patient can afford ovulation induction, when needed, pregnancy and labour, with an acceptable degree of risk, and which are the limits of this risk. As regards the possibility to induce a pregnancy in women affected by such disease, this activity was judged to be *perfectly moral from the chatolic point of view* by the Center for Bioethics of the Chatolic University of the Sacred Heart, Rome, as it was explained in previous studies regarding this matter.^[@R15]^

Finally, the improvements of current conventional treatments, especially in the management of iron deposits, the prolongation of survival rate, and the new approaches to assisted conception, when needed, will result in a continuous increase of pregnancies in women affected by beta Thalassemia. According to the several advances in treatment, occurred from the 1980s, and to periconceptional counselling - concerning the continuation of pregnancy only in women in good general conditions - intrauterine growth retardation, foetal loss and preterm labour are remarkably reducing.

Concluding we can state that pregnancy is now a real possibility for women affected by Cooley disease that are regularly transfused and well chelated. Pregnancy does not have a deleterious effect on the course of their disease, and on the general well being of the foetus. It seems, in fact, that the evaluation of cardiac function, in combination with a low iron load and satisfactory endocrine and hepatic controls can ensure a pregnancy outcome with minimal adverse effects, and not severe obstetric complications except for the high incidence of caesarean sections.^[@R16]^

Then it is possible to think about a normal pregnancy without fetal loss, foetus\' intrauterine growth retardation and preterm labour, like it is commonly believed. We are furthermore studying the possibility to collect a good quantity of umbilical cord blood of the foetus, after the delivery and before placental detachment, to attempt eterologus transplantation to the mother ([Figure 3](#F3){ref-type="fig"}).^[@R17]^ This is to be hoped, especially if the mother is totally HLA-matched or also partially matched with her son, because umbilical cord blood has shown to possess a significant quantity of CD34^+^ stem cells. These particular haematological stem cells have a great capacity to repopulate the bone marrow and now are being used to intent an alternative approach to several both malignant and not haematological disease. So, by using this procedure, after several laboratory passages of CD34^+^ recovering, metabolism monitoring, enrichment and clonogenic culture, we aim at trying to get a complete marrow reconstitution of the thalassemic mother, thanks to the help offered by her donor son.

Figure 3Photograph showing the collection of umbilical cord blood, containing a large quantity of CD34+ stem cells, during a caesarean section, in a thalassemic woman.
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